Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation | Nature Communications
The diagnostic conundrum in non-alcoholic fatty liver disease
Frontiers | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?
Current treatment of non‐alcoholic fatty liver disease - Paternostro - 2022 - Journal of Internal Medicine - Wiley Online Library
Non-alcoholic fatty liver disease | RCP Journals
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
IJMS | Free Full-Text | Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach | HTML
Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis | Scientific Reports
Frontiers | Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
Biomedicines | Free Full-Text | Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis | HTML
Frontiers | Gut Dysfunction and Non-alcoholic Fatty Liver Disease
New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis | SpringerLink
Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2 Diabetes - Endotext - NCBI Bookshelf
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology
A global view of the interplay between non-alcoholic fatty liver disease and diabetes - The Lancet Diabetes & Endocrinology
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
Cureus | A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Frontiers | Hepatic Macrophage as a Key Player in Fatty Liver Disease
Non-alcoholic fatty liver disease publications and distribution of... | Download Scientific Diagram
Nonalcoholic Fatty Liver Disease | North Carolina Medical Journal
Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D) | Scientific Reports
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development | HTML
Molecules | Free Full-Text | Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis | HTML
